Importance of time in therapeutic range on bleeding risk prediction using clinical risk scores in patients with atrial fibrillation
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Importance of time in therapeutic range on bleeding risk prediction using clinical risk scores in patients with atrial fibrillation
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-09-15
DOI
10.1038/s41598-017-11683-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation of the HAS-BLED, ATRIA, and ORBIT Bleeding Risk Scores in Patients with Atrial Fibrillation Taking Warfarin
- (2016) Keitaro Senoo et al. AMERICAN JOURNAL OF MEDICINE
- Predictive ability of HAS-BLED, HEMORR2HAGES, and ATRIA bleeding risk scores in patients with atrial fibrillation. A French nationwide cross-sectional study
- (2016) Laurent Fauchier et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Predictive abilities of the HAS-BLED and ORBIT bleeding risk scores in non-warfarin anticoagulated atrial fibrillation patients: An ancillary analysis from the AMADEUS trial
- (2016) Keitaro Senoo et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Bleeding risk assessment in atrial fibrillation: observations on the use and misuse of bleeding risk scores
- (2016) G. Y. H. Lip et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Assessing Bleeding Risk With the HAS-BLED Score: Balancing Simplicity, Practicality, and Predictive Value in Bleeding-Risk Assessment
- (2015) Gregory Y. H. Lip CLINICAL CARDIOLOGY
- The HAS-BLED Score for Predicting Major Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: A Systematic Review and Meta-analysis
- (2015) Wengen Zhu et al. CLINICAL CARDIOLOGY
- Validation of the SAMe-TT2R2 score in a nationwide population of nonvalvular atrial fibrillation patients on vitamin K antagonists
- (2015) Vicente Bertomeu et al. THROMBOSIS AND HAEMOSTASIS
- The importance of excellence in the quality of anticoagulation control whilst taking vitamin K antagonists
- (2015) Francisco Marín et al. THROMBOSIS AND HAEMOSTASIS
- Comparative evaluation of HAS-BLED and ATRIA scores by investigating the full potential of their bleeding prediction schemes in non-valvular atrial fibrillation patients on vitamin-K antagonists
- (2014) Rami Riziq-Yousef Abumuaileq et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Performance of the HAS-BLED high bleeding-risk category, compared to ATRIA and HEMORR2HAGES in patients with atrial fibrillation: a systematic review and meta-analysis
- (2014) Daniel Caldeira et al. JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY
- Factors Affecting Quality of Anticoagulation Control Among Patients With Atrial Fibrillation on Warfarin
- (2013) Stavros Apostolakis et al. CHEST
- Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation
- (2013) Pilar Gallego et al. THROMBOSIS AND HAEMOSTASIS
- Vitamin K antagonists in heart disease: Current status and perspectives (Section III)
- (2013) Raffaele Caterina et al. THROMBOSIS AND HAEMOSTASIS
- Predictive Value of the HAS-BLED and ATRIA Bleeding Scores for the Risk of Serious Bleeding in a “Real-World” Population With Atrial Fibrillation Receiving Anticoagulant Therapy
- (2012) Vanessa Roldán et al. CHEST
- Relation of the HAS-BLED Bleeding Risk Score to Major Bleeding, Cardiovascular Events, and Mortality in Anticoagulated Patients With Atrial Fibrillation
- (2012) Pilar Gallego et al. Circulation-Arrhythmia and Electrophysiology
- Assessing the Risk of Bleeding in Patients With Atrial Fibrillation
- (2012) Gregory Y. H. Lip et al. Circulation-Arrhythmia and Electrophysiology
- 2012 focused update of the ESC Guidelines for the management of atrial fibrillation
- (2012) et al. EUROPEAN HEART JOURNAL
- Performance of the HEMORR2HAGES, ATRIA, and HAS-BLED Bleeding Risk–Prediction Scores in Patients With Atrial Fibrillation Undergoing Anticoagulation
- (2012) Stavros Apostolakis et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Performance of the HEMORR2HAGES, ATRIA, and HAS-BLED Bleeding Risk–Prediction Scores in Nonwarfarin Anticoagulated Atrial Fibrillation Patients
- (2012) Stavros Apostolakis et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A New Risk Scheme to Predict Warfarin-Associated Hemorrhage
- (2011) Margaret C. Fang et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients
- (2011) Arlene Gallagher et al. THROMBOSIS AND HAEMOSTASIS
- Stroke Risk and Antithrombotic Strategies in Atrial Fibrillation
- (2010) Caroline Medi et al. STROKE
- Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers
- (2008) Andrew J Vickers et al. BMC Medical Informatics and Decision Making
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started